Furthermore, immunohistochemistry (IHC) of tumor biopsies showed increased hTERT expression in tumor xenografts, resulting in decreased level of p53 and upregulation of bcl-2 expression, subsequently suppression of cleavages of pro-caspase-3. The gene discussed is BCL2; the disease is neoplasm.